Seeing Is Believing
XENE is currently covered by 10 analysts with an average price target of $52.14. This is a potential upside of $12.64 (32%) from yesterday's end of day stock price of $39.5.
Xenon Pharmaceuticals's activity chart (see below) currently has 36 price targets and 76 ratings on display. The stock rating distribution of XENE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 60.86% with an average time for these price targets to be met of 500 days.
Highest price target for XENE is $62, Lowest price target is $49, average price target is $52.14.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 12-Apr-2024. First documented stock forecast 01-Dec-2014.
Currently out of the existing stock ratings of XENE, 35 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
62
$22.5 (56.96%)
62
13 days ago
8/10 (80%)
$20.7 (50.12%)
450
Buy
51
$11.5 (29.11%)
46
1 months 24 days ago
9/10 (90%)
$4.16 (8.88%)
430
Buy
55
$15.5 (39.24%)
56
1 months 24 days ago
5/11 (45.45%)
$8.16 (17.42%)
492
Buy
56
$16.5 (41.77%)
52
3 months 23 days ago
1/3 (33.33%)
$11.09 (24.69%)
528
Buy
62
$22.5 (56.96%)
44
4 months 7 days ago
3/4 (75%)
$20.85 (50.67%)
512
What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?